use of 3 % dextran-60 as a plasma substitute in blood component therapy for surgical hemorrhage of up to 50 % of the calculated blood volume caused no increase in bleeding tendency or frequency of postoperative hematoma compared with whole blood replacement .
C0086140
dextran
C0005779
bleeding tendency